The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Government NewsFull Access

Bill Targets Rx Drug Advertising

Published Online:https://doi.org/10.1176/pn.38.20.0010c

Rep. Pete Stark (D-Calif.) introduced the Fair Balance Prescription Drug Advertisement Act of 2003 (HR 3155) in late September.

The legislation would eliminate the corporate advertising tax deduction for direct-to-consumer prescription-drug advertisements that do not present the benefits and risks of the medications they promote “in a fairly balanced manner,” according to a September 23 press release.

The act would require that print advertisements display a drug’s pros and cons in same-sized typeface and space and on the same or facing pages. Risk and benefit descriptions would be allotted equal airtime for television and radio advertisements.

The California Public Employees’ Retirement System, which provides health benefits to more than 1.3 million members, endorsed the proposed legislation.

More information about the bill is posted on the Web at www.house.gov/stark under “Legislation.”